BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mylan Inc. (MYL) Announces $1 Million Gift to the Pittsburgh Promise Scholarship Fund


4/22/2013 11:14:18 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PITTSBURGH, April 22, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has contributed $1 million to The Pittsburgh Promise Scholarship Fund, a scholarship program for Pittsburgh Public School students that advocates for improving the quality of education and increasing the preparedness and diversity of the region's workforce. The donation will help The Pittsburgh Promise to complete phase II of their $250 million fundraising campaign nearly three years ahead of the fund's original 2018 target.

Mylan Executive Chairman Robert J. Coury said, "Mylan has and will continue to play an active role in Pittsburgh, as we believe strongly in the importance of giving back to our community. Pittsburgh has long served as an important hub to Mylan and we anticipate it will continue to play a key role in our business for many years, as we look forward the opening of our new Global Center later this year.

"With this donation to The Pittsburgh Promise, we are proud to invest in the future of the region's children through enhanced educational opportunities and believe this contribution will only further build on the strength of our community and its people in the future."

Mylan CEO Heather Bresch commented, "Our pledge supports the hope that students in our own backyard receive an education after high school and helps break down the financial barriers that could keep them from making their dreams come true. We are pleased to support one of the country's leading scholarship programs that advances public education reform, while preparing our young people for jobs in science and business."

Pittsburgh Promise scholars have enrolled in 91 different post-secondary public and private colleges and universities, career training companies, and vocational and trade programs throughout the Commonwealth of Pennsylvania. Pittsburgh has the largest Promise program in the United States. Reaching the program's financial goals sooner than previously expected will help to ensure that the Promise can continue making progress on its mission to advance the lives of young people for many years to come.

Since the Pittsburgh Promise was launched in 2007, $160 million has been raised in gifts and pledges from more than 100 corporations and foundations, and more than 2,000 individual donors. The Promise has provided $32 million in scholarships to 3,800 graduates from the Pittsburgh Public Schools classes of 2008 2012.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com

SOURCE Mylan Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES